论文部分内容阅读
loratadine 是一种新的、无镇静作用的抗组胺药,正等待美国FDA 批准。近期已在5个国家出售,并计划在8个国家(包括美国)出售。无镇静作用的抗组胺药已迅速受到过敏患
Loratadine is a new, non-sedating antihistamine that is awaiting FDA approval. It has recently been sold in five countries and is scheduled to be sold in eight countries, including the United States. Antihistamines that have no sedative effect have been rapidly affected by allergies